Table 2.
Group | n | AST (U/L) | ALT (U/L) |
---|---|---|---|
Control group | 10 | 26.27±6.85 | 27.56±14.72 |
CCl4-model group | 10 | 143.66±7.41# | 121.34±11.78# |
Low GSP dose group | 10 | 85.91±6.63#,* | 113.46±12.14# |
Moderate GSP dose group | 10 | 73.78±6.15#,*,$ | 98.25±16.47#,*,$ |
High GSP dose group | 10 | 61.62±8.28#,*,$,& | 68.46±12.78#,*,$,& |
DDB group | 10 | 60.32±6.19#,* | 63.56±14.32#,*,$,& |
CCl4 – carbon tetrachloride; GSP – grape seed proanthocyanidins; DDB – bifendate; ALT – alanine aminotransferase; AST – aspartate aminotransferase;
P<0.01,compared with the control group;
P<0.05, compared with the CCl4-model group;
P<0.05, compared with the low GSP dose group;
P<0.05, compared with the moderate GSP dose group.